Plasminogen
From Proteopedia
(Difference between revisions)
Line 23: | Line 23: | ||
*Plasminogen | *Plasminogen | ||
- | **[[4dur]], [[4duu]], [[4a5t]] – hPLG 2 - human | + | **[[4dur]], [[4duu]], [[4a5t]] – hPLG 2 residues 20-810 - human<br /> |
+ | **[[2kj4]] – hPLG residues 1-83 + M2 protein peptide – NMR<BR /> | ||
- | *Plasminogen kringle 1 | + | *Plasminogen kringle 1 residues 101-181 |
**[[1pkr]] - hPLG kringle 1 <BR /> | **[[1pkr]] - hPLG kringle 1 <BR /> | ||
Line 33: | Line 34: | ||
**[[4cik]] - hPLG kringle 1 + inhibitor<br /> | **[[4cik]] - hPLG kringle 1 + inhibitor<br /> | ||
- | *Plasminogen kringle 2 | + | *Plasminogen kringle 2 residues 181-263 |
**[[1b2i]] - hPLG kringle 2 (mutant) – NMR<BR /> | **[[1b2i]] - hPLG kringle 2 (mutant) – NMR<BR /> | ||
**[[1i5k]] - hPLG kringle 2 (mutant) + M2 protein peptide<BR /> | **[[1i5k]] - hPLG kringle 2 (mutant) + M2 protein peptide<BR /> | ||
- | **[[2kj4]] – hPLG kringle 2 + M2 protein peptide – NMR<BR /> | ||
- | *Plasminogen kringle 3 | + | *Plasminogen kringle 3 resides 272-354 |
**[[2l0s]] - hPLG kringle 3 – NMR<BR /> | **[[2l0s]] - hPLG kringle 3 – NMR<BR /> | ||
- | *Plasminogen kringle 4 | + | *Plasminogen kringle 4 resides 375-454 |
**[[1pk4]], [[1pmk]], [[1pml]], [[1krn]] – hPLG kringle 4<BR /> | **[[1pk4]], [[1pmk]], [[1pml]], [[1krn]] – hPLG kringle 4<BR /> | ||
**[[2pk4]] - hPLG kringle 4 + e-aminocaprioic acid | **[[2pk4]] - hPLG kringle 4 + e-aminocaprioic acid | ||
- | *Plasminogen kringle 5 | + | *Plasminogen kringle 5 resides 480-563 |
**[[5hpg]] - hPLG kringle 5<BR /> | **[[5hpg]] - hPLG kringle 5<BR /> | ||
**[[2knf]] - hPLG kringle 5 – NMR<BR /> | **[[2knf]] - hPLG kringle 5 – NMR<BR /> | ||
- | *Plasminogen catalytic domain | + | *Plasminogen catalytic domain residues 543-791 |
**[[1qrz]], [[1ddj]], [[1rjx]] – hPLG catalytic domain (mutant)<br /> | **[[1qrz]], [[1ddj]], [[1rjx]] – hPLG catalytic domain (mutant)<br /> |
Revision as of 08:03, 22 August 2018
|
3D Structures of plasminogen
Updated on 22-August-2018
References
- ↑ Goldenberg DT, Giblin FJ, Cheng M, Chintala SK, Trese MT, Drenser KA, Ruby AJ. Posterior vitreous detachment with microplasmin alters the retinal penetration of intravitreal bevacizumab (Avastin) in rabbit eyes. Retina. 2011 Feb;31(2):393-400. doi: 10.1097/IAE.0b013e3181e586b2. PMID:21099453 doi:http://dx.doi.org/10.1097/IAE.0b013e3181e586b2
- ↑ Mehta R, Shapiro AD. Plasminogen deficiency. Haemophilia. 2008 Nov;14(6):1261-8. doi: 10.1111/j.1365-2516.2008.01825.x. PMID:19141167 doi:http://dx.doi.org/10.1111/j.1365-2516.2008.01825.x
- ↑ Law RH, Caradoc-Davies T, Cowieson N, Horvath AJ, Quek AJ, Encarnacao JA, Steer D, Cowan A, Zhang Q, Lu BG, Pike RN, Smith AI, Coughlin PB, Whisstock JC. The X-ray crystal structure of full-length human plasminogen. Cell Rep. 2012 Mar 29;1(3):185-90. doi: 10.1016/j.celrep.2012.02.012. Epub 2012, Mar 8. PMID:22832192 doi:10.1016/j.celrep.2012.02.012